Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference32 articles.
1. Focus on breast cancer;Baselga;Cancer Cell,2002
2. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients;Kröger;Clin. Cancer. Res.,2006
3. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment);Sutherland;Cancer,1985
4. Tailoring therapies–improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015;Coates;Ann. Oncol.,2015
5. Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades;Haque;Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol.,2012
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09
2. Therapeutic prospects of nectin-4 in cancer: applications and value;Frontiers in Oncology;2024-03-28
3. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4;Frontiers in Immunology;2024-01-15
4. Nectin-4: A promising prognostic marker and therapeutic target in cancer;International Review of Cell and Molecular Biology;2024
5. Nectin-4 has emerged as a compelling target for breast cancer;European Journal of Pharmacology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3